NVIDIA Isaac Lab contains a vulnerability where an attacker could cause an eval injection.

published 2026-10-13 27 d ago modified 2026-10-13 27 d ago also EUVD-2026-98545

cvss: 7.8; version 3.1, CNA
cisa kev: Not listed; not in CISA's catalog
epss: 0.2%; EPSS 0.2% chance of exploitation in 30 days, percentile 5%
public exploits: 0; none known

NVIDIA Isaac Lab contains a vulnerability where an attacker could cause an eval injection. A successful exploit of this vulnerability might lead to code execution, information disclosure, data tampering, and denial of service.

Patch / fix

fixed in 1

nvidia isaac_lab 3.0-beta2

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

red hat product security vex CVE-2026-65141 updated 2026-11-05 cvss 7.8

isaac-lab: isaac-lab: Arbitrary code execution via eval injection

Red Hat All currently supported Red Hat products
not affected: vulnerable code not present

Red Hat CSAF VEX © Red Hat, Inc., from https://security.access.redhat.com/data/csaf/v2/vex/; changed: reduced to product statuses and remediations. CC BY 4.0 · csaf

CISA SSVC

Exploitation: none
Automatable: no
Technical impact: total
Assessed: 27 d ago (2026-10-13)

Exploit prediction

0.17% chance of exploitation in the next 30 days, higher than 5% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by	version	score	vector
CNA	3.1	7.8	CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Affected products

NVIDIA Isaac Lab

Classification

Weakness

CWE-95 Improper Neutralization of Directives in Dynamically Evaluated Code

References

Sources

CVE List CVE-2026-65141
NVD CVE-2026-65141

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.

Summary